Bristol's Big Bet on Hep C Crashes - Aug. 2, 2012

Having trouble viewing this email? View in Browser.

Thursday, August 02, 2012  |   |   |   |  FIRST LATIN AMERICAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS A Hybrid Conference and Internet Event Sponsored by Latin American Ethics and Compliance Network Cosponsored by Pharmaceutical Compliance Forum Media Partners: Life Science Compliance and RX Compliance Report October 2 - 4, 2012 Hilton Sao Paulo Morumbi Sao Paulo, Brazil Please click here for more information. •  Bristol-Myers Squibb Company (BMY)'s Big Bet on Hep C Crashes More... •  Endocyte, Inc. (ECYT) Secures DOXIL® Supply to Support Ongoing Phase 3 PROCEED Trial in Ovarian Cancer More... •  ViroPharma Incorporated (VPHM) Provides Update on Phase 2 Clinical Evaluation of Subcutaneous Cinryze® (C1 Esterase Inhibitor [Human]) With Recombinant Human Hyaluronidase (rHuPH20) More... •  DBV Technologies Initiates VIPES Phase IIb Clinical Study, the First Global Trial Ever in Desensitization of Peanut-Allergic Children and Adults More... •  Spectrum Pharmaceuticals, Inc. (SPPI) Announces Publication in the Journal of Clinical Oncology of Encouraging ZEVALIN Data in Patients With Mantle-Cell Lymphoma More... More Phase III News More Phase II News More Phase I News More Pre-Clinical News More Post-Approval News •  Halozyme Therapeutics, Inc. (HALO) Plummets on FDA Safety Questions; Stock Down - 4.30(50.23%) @ 1:07PM EDT More... More BLA/NDA/ANDA News More IND News More MAA News CHI's Fourth Annual ADAPT 2012: Accelerating Development & Advancing Personalized Therapy Congress, will be held at the in Washington, DC, September 19-21, 2012. Delegates from pharma and diagnostic companies, clinical organizations, academia, and government, will be provided a unique opportunity to learn and discover actionable strategies bridging drug and diagnostic development. Please click here for more information. •  A Cup of Joe a Day Keeps Parkinson's Away? McGill University Study More... •  Pets May Help Kids With Autism Develop Social Skills, Hospital Bohars Study More... •  Chronic Fatigue Syndrome: Brain Training is Most Cost-Effective Treatment, PLos ONE Reveals More... •  Depression Could Shorten Cancer Survival, University of Texas Study More... •  Advaxis, Inc. Release: University of Pennsylvania Doses First Two Dogs in ADXS-HER2 Canine Osteosarcoma Study More... More General Clinical Research News • Pharm Country (Princeton, New Jersey) Otsuka America Pharmaceutical, Inc. Associate Director Clinical Management Acts as the scientific lead for clinical program development activities within a product group or within a portfolio. Determines product and portfolio level standards for clinical development planning, scientific document content, data analysis and reporting, and reporting to senior management, OPCJ and affiliates. • Southern Pharm (Miami, Florida) Cubist Pharmaceuticals, Inc. Clinical Business Manager Responsible for achieving and maximizing territory and account sales goals through account management, high level clinical proficiency and effective selling. The CBM will be the primary point of contact for Cubist with key hospital influencers and decision makers across key functional areas including but not limited to physicians, pharmacists and formulary committee members. • BioMidwest (Northbrook, Illinois) Astellas Pharma US Associate Clinical Program Director Provide strategic input into clinical development plans, GMAP and other key global project team deliverables through participation on global project team. Deliver and manage the operational plan including budget, resources and timelines to global project team. • BioForest (Lake Oswego, Oregon) Galena Biopharma Global Clinical Project Manager Responsible for the planning, development, implementation and ongoing management of all of the operational aspects of clinical trials including protocol development, defining scope of work, resource planning and allocation, recruitment of clinical investigators, training, planning and execution of investigator meetings, establishment and adherence to timelines, ensuring compliance with protocols and clinical/corporate objectives, adherence to regulations and company Standard Operating Procedures (SOPs), and clinical supply management. • Biotech Bay (Foster City, California) Gilead Sciences Associate Director, Clinical Research Will primarily support the GS-7340 project, a new nucleotide reverse transcriptase inhibitor in development for the treatment of HIV, though work on other HIV development projects may also be required. • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! 2012 Pharm Country Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the tri-state area. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Pharm Country Career Fair, Bridgewater, NJ September 13, 2012 • Biotech Beach Career Fair, San Diego, CA September 20, 2012 • Biotech Bay Career Fair, Burlingame, CA October 3, 2012 • BioCapital Career Fair, Bethesda, MD October 9, 2012 • BioMidwest Career Fair, Lincolnshire, IL October 22, 2012 • Bio NC Career Fair, Durham, NC October 25, 2012 • Genetown Career Fair, Cambridge, MA November 5, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience •  NeurogesX, Inc. (NGSX) Receives Additional Notice of Allowance Covering NGX-1998 in U.S. More... •  ZIOPHARM Oncology, Inc. (ZIOP.OB) Granted New U.S. Patent for Palifosfamide More... •  Insmed Incorporated (INSM) Receives Second Composition of Matter Patent for ARIKACE® More... More Patent News Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! Biomarkers in Late Stage Clinical Trials • Quantify and analyze revenues of late stage biomarker technology and services in North America, Europe, Asia and the Rest of the World. • Identify the key market drivers and resistors of the biomarker market and evaluate the growth potential of emerging technologies. • Assess biomarker activity at leading companies, including Abbott, AZ, BMS, Eli Lilly, GSK, Merck & Co, Novartis, Pfizer, Roche and Sanofi-Aventis. Click Here for More Information. Hot Company Dynavax Technologies Corporation 2929 Seventh Street, Suite 100 Berkeley, California 94710 U.S.A. Phone: 510-848-5100 Fax: 510-848-1379 Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. More Company Profiles Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship ClinicaSpace 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 ClinicaSpace 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the ClinicaSpace News Beat Team. Editor & Publisher: Lana Ho Editorial & Production Staff: Maysa Darwish, Tammy Liu ClinicaSpace.com - Clinical Trials. Clinical Research. Community. • ClinicaSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 ClinicaSpace http://www.clinicaspace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.